| Thomas J. Schuetz, M.D., Ph.D. | Chief Executive Officer | FY2025 | |
| Barry Shin | Chief Financial Officer | FY2025 | |
| Jonathan Anderman | General Counsel and Corporate Secretary | FY2024 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.